Release Date: 25/02/09 18:35 Summary: Interim Results 2009 and Fund Update Price Sensitive: Yes Download Document 5.87MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%